Related Experiment Video
Updated: Sep 3, 2025

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice
Published on: July 2, 2018
Loop Diuretic Use is Associated With Adverse Clinical Outcomes in Acute Myocardial Infarction Patients With Low
Tsutomu Kawai1, Daisaku Nakatani2, Tetsuya Watanabe1
1Division of Cardiology, Osaka General Medical Center, Osaka, Japan.
Insights
Loop diuretic use after acute myocardial infarction (AMI) increases poor prognosis risk in patients with low plasma volume status. Careful observation is needed for these AMI patients without plasma volume expansion.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Medicine
Background:
- Acute myocardial infarction (AMI) management involves addressing fluid balance.
- Loop diuretics are commonly prescribed, but their impact on prognosis varies.
- Plasma volume status is a critical factor in cardiovascular outcomes.
Purpose of the Study:
- To investigate the prognostic impact of loop diuretics in AMI patients.
- To assess if plasma volume status modifies the effect of loop diuretics.
- To determine optimal diuretic use in post-AMI care.
Main Methods:
- Study included 3,364 AMI survivors from the Osaka Acute Coronary Insufficiency Study (OACIS) database.
- Plasma volume status assessed by estimated plasma volume status (ePVS) at discharge.
- Composite endpoint of all-cause death and heart failure rehospitalization over 5 years.
Main Results:
- Loop diuretic use was linked to increased risk in patients with low ePVS (HR 2.572).
- No significant increased risk was observed in patients with high ePVS (HR 1.028).
- Findings remained consistent in propensity-score matched cohorts.
Conclusions:
- Loop diuretic prescription at discharge is associated with poor prognosis in AMI patients without plasma volume expansion.
- Careful monitoring is essential when prescribing loop diuretics for AMI patients with low plasma volume.
- Plasma volume status is a key determinant of loop diuretic efficacy and safety post-AMI.
Abstract:
To investigate the difference in the prognostic impact of loop diuretics in patients with acute myocardial infarction (AMI) based on plasma volume status, a total of 3,364 survivors of AMI who were registered in the large database of the Osaka Acute Coronary Insufficiency Study (OACIS) were studied. Plasma volume status was assessed by the estimated plasma volume status (ePVS) that was calculated based on a weight- and hematocrit-based formula at discharge. The endpoint was a composite endpoint of all-cause death and rehospitalization due to heart failure for 5 years. During a median follow-up period of 1.9 years, 90 and 223 patients had events in the groups with low ePVS (
Related Concept Videos
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Acute Kidney Injury VI: Nursing Management
Antihypertensive Drugs: Action of Diuretics

